TITLE 71 INDIANA HORSE RACING COMMISSION
Emergency Rule
LSA Document #12-72(E)
DIGEST
Authority:
IC 4-31-3-9
Sec. 4.2.
The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:
(1) The use of clenbuterol shall be permitted under the following conditions: Not to exceed the following permitted serum or plasma threshold concentrations twenty-five (25) picograms per milliliter of clenbuterol (or its metabolites) which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Standardbred - 25 picograms per milliliter. in serum or plasma.
(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.
(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8-1-1 [section 1 of this rule].
Authority:
IC 4-31-3-9
Sec. 4.2.
The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:
(1) The use of clenbuterol shall be permitted under the following conditions:
(1) (A) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Thoroughbred – twenty-five (25) picograms per milliliter.
(2) (B) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of thirty (30) days: Quarter horse – two (2) picograms per milliliter.
(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.
(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8.5-1-1 [section 1 of this rule].
Filed with Publisher: February 8, 2012, 12:01 p.m.
Posted: 02/15/2012 by Legislative Services Agency
DIN: 20120215-IR-071120072ERA
Composed: Apr 24,2024 9:47:41PM EDT
A
PDF version of this document.
